Facility in The Woodlands, Texas to produce critical starting material for cell and gene therapy, DNA/RNA-based, and recombinant protein therapeutics in Q1/2025
mRESVIA is Moderna's second approved product and the only RSV vaccine available in single-dose pre-filled syringes
Strategic focus on India aims to make the Swoop® portable MR brain imaging system commercially available in a vast and underserved MRI market
Greg was also central to the planning, design, and construction of this facility
The approval of YESAFILI marks Biocon Biologics’ expansion into the ophthalmology therapeutic area in the United States
Investing considerably in production capacity for medical device packaging at its Rohrdorf and Halle sites in Germany
Subcutaneous nivolumab has potential to be the first and only subcutaneously administered PD-1 inhibitor
Wipro's MPPP360 platform will assist Independent Health in streamlining the payment process to seamlessly integrate these new provisions
GAAP net loss of $1.2 billion and GAAP diluted EPS of $(3.07)
Philips also concluded an agreement with insurers to pay Philips EUR 540 million to cover Respironics recall-related product liability claims
Subscribe To Our Newsletter & Stay Updated
